Menu
OR
OR
Late Sodium Channel Inhibitors in CCS Management

Cardiology - Clinical Cardiology

loading

This infographic provides a concise overview of the 2024 ESC Guidelines for the management of chronic coronary syndrome (CCS), emphasizing a patient-centred approach to the selection and optimization of antianginal therapy. It highlights the role of late sodium current inhibitors, such as ranolazine, in patients with persistent anginal symptoms despite first-line antianginal therapy. Treatment selection should be individualized according to heart rate, blood pressure, left ventricular function, comorbidities, concomitant therapies, and patient preferences. The overall approach aims to achieve effective angina control, improve health-related quality of life, and support treatment adherence through individualized therapeutic strategies.


0 Likes

0 Comments


Profile
MedBytes

MedBytes Forum brings essential medical insights to life through concise, visually engaging infographics created for healthcare professionals. Covering diverse therapeutic areas and medical communities, it delivers key evidence, clinical updates, and practice-relevant information in a clear, quick-read format to help HCPs stay informed efficiently.

© 2026 Imedsource, All Rights Reserved

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.